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Abstract
Building on Yu and Kumbier’s PCS framework and for randomized experiments, we introduce
a novel methodology for Stable Discovery of Interpretable Subgroups via Calibration (StaDISC),
with large heterogeneous treatment effects. StaDISC was developed during our re-analysis of the
1999-2000 VIGOR study, an 8076 patient randomized controlled trial, that compared the risk
of adverse events from a then newly approved drug, Rofecoxib (Vioxx), to that from an older
drug Naproxen. Vioxx was found to, on average and in comparison to Naproxen, reduce the risk
of gastrointestinal (GI) events but increase the risk of thrombotic cardiovascular (TC) events.
Applying StaDISC, we fit 18 popular conditional average treatment effect (CATE) estimators
for both outcomes and use calibration to demonstrate their poor global performance. However,
they are locally well-calibrated and stable, enabling the identification of patient groups with
larger than (estimated) average treatment effects. In fact, StaDISC discovers three clinically
interpretable subgroups for the GI outcome (totaling 29.4% of the study size), and two (totaling
5.6%) for the TC outcome. Amongst them, the subgroup of people with a prior history of GI
events (7.8% of the study size) not only has a disproportionately reduced risk of GI events but
also does not experience an increased risk of TC events.
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1 Introduction
Since its inception, the field of statistics has aimed to produce tools to help scientists seek scientific
truth. Scientific truth, however, is not of a singular quality. While some relations in physics like
Hooke’s law are made apparent using simple linear regression, questions dealing with complex,
emergent phenomena such as the efficacy of drugs or job training programs seem to have more
contingent answers. It was the urge to formalize and investigate such questions that begot and
nurtured the field of causal inference in statistics over the past century. One of the two most
influential frameworks for causal inference, the Neyman-Rubin causal model [30], has its roots in
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Fisher and Neyman’s [23, 60, 47] work on randomized experiments for agriculture, and was later
codified by Rubin [57], who was then interested in psychometrics.1
Historically, causal inference researchers have used traditional regression methods in their anal-
yses, with econometricians in particular developing a comprehensive theory of drawing inference
from linear models [2]. This is rapidly changing, however, with recent works [3, 37, 14, 42] bringing
in machine learning tools to tackle causal inference problems, one genre of which has been the
investigation of heterogeneous treatment effects.
1.1 Heterogeneous treatment effects
In both randomized experiments as well as observational studies, apart from the treatment and
response variables, additional pre-treatment information is often known about the study subjects.
For instance, information on medical risk factors is collected in clinical trials, while demographic
and socioeconomic data is collected in social science studies. Such side information has always been
important because it allows us to adjust for confounding in observational studies, and also to create
more efficient estimators in randomized experiments [38, 33].
In addition to these uses, researchers are also increasingly interested in drawing inference about
how the effect of a treatment varies depending on an individual’s observed covariates. The past
decade in particular has witnessed a wave of innovation in the modeling and estimation of het-
erogeneous treatment effects. Underlying the hot topic of precision medicine [15] is a realization
that how a patient responds to a particular drug or treatment depends on the patient’s genetics,
lifestyle and environment, and that consequently, accounting for these differences will allow doctors
to deliver better and more targeted care. Moreover, this emphasis on understanding and exploit-
ing heterogeneity is not unique to the biomedical sciences, and has also arisen in economics [34],
political sciences [26, 22], online advertising [40], and many other fields [22].
Broadly speaking, methodological research on heterogeneous treatment effects can be put into
two categories: (i) conditional average treatment effect (CATE) function estimation [34, 26, 22, 10,
24, 62, 6], and (ii) subgroup analysis, [64, 52, 4, 39] with the latter having a longer history. Here
we attempt a brief review of the existing literature, and refer the readers to referenced papers for
further background.
CATE Estimation: For a binary treatment, the CATE is defined to be the expected difference
between the potential outcome under treatment and that under no treatment, conditional on a
subject’s observed covariates (see Section 3 for formal definitions). While the average treatment
effect (ATE) is a scalar quantity, the CATE is a function and thus far more challenging to estimate.
Because one observes only one of the two potential outcomes for every individual—an issue referred
to as the fundamental problem of missing data in causal inference [30]—one cannot directly solve
this problem using the conventional supervised learning techniques.
1With important extensions also by Cox [16].
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Over the past decade or so, researchers have made tremendous progress with CATE estimation
and proposed numerous methods for it [34, 26, 22, 10, 24, 62, 6]. A large fraction of these [34,
22, 10, 6] fall under the framework of meta-learners. These are “meta-algorithms [that] decompose
estimating the CATE into several regression sub-problems that can be solved with any regression or
supervised learning method” [37]. Some of these meta-algorithms are fairly obvious. For instance,
the T -learner strategy [24] comprises fitting models for the two response functions (the conditional
expectation of each potential outcome), and then taking their difference. Others, such as the X-
learner [37] and R-learner [49] strategies, are more sophisticated, and require more notation to
explain (see Section 4.1 for further details). Not all proposed algorithms follow a meta-learner
strategy, the popular causal tree and causal forest algorithms [4, 63] being prominent examples.
Concerns with model choice for CATE Estimation: With such a diverse range of esti-
mators, most of which come with hyperparameters, model choice becomes a primary concern.
Some researchers have used asymptotic efficiency [49, 35] to establish when certain estimators can
be definitely favored under (uncheckable) generative models. Such arguments, however, rely on
smoothness assumptions and asymptotic data regimes that are typically hard to verify for the
problems typically considered by causal inference researchers. Meanwhile, plug-in prediction accu-
racy on holdout test sets is frequently used to do model selection in supervised learning, but this
is infeasible for CATE estimation due to the data missingness we alluded to earlier. To circumvent
this issue, researchers have formulated proxy loss functions [58] for data-driven model choice, with
ideas including using nearest neighbor matching [55], kernel-based local linear squares fit [10], and
influence functions [1]. These model choice methods, however, have only been justified using sim-
ulations often in strong signal regime, a scenario that does not hold in many if not most real data
problems (including the one considered in this work).
Concerns with model validation for CATE Estimation: Before deciding which estimator
to choose for a given task, we would first like to know whether there is even enough signal in the
data to fit a generalizable model. Again, data missingness means that there is no clear answer to
this problem. The proxy loss functions are not good substitutes for quantities like R2 or ROC AUC
scores because they can be noisy, and furthermore they do not have an easily interpretable scale.
This is especially concerning because randomized experiments often have low signal strength.2
Subgroup analysis: An older approach to investigating heterogeneity is through “subgroup
analysis”. The goal here is to identify subgroups of subjects in the study over which the treatment
effect is significantly larger or smaller than that the population average. Such a conception of
heterogeneity has two advantages over CATE estimation: (a) It is less ambitious, and thus promises
to be more tractable given the low data regime in real settings, and (b) it is often more aligned with
the downstream tasks involving decision-making (e.g., identifying which subgroup of individuals to
2Budget constraints would dictate that they be only sufficiently powered to detect the ATE.
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treat).
Traditionally, for subgroup analysis, researchers check the treatment effect over a pre-determined
list of subgroups which are suggested by prior domain knowledge. Doing this, however, ignores po-
tential unforeseen heterogeneity in the data, and there has been much recent work on how to
conduct a data-driven search for subgroups. Naive searching can quickly overfit3, so any search
method has to balance aggressiveness of searching with the need to account for multiple testing.
Proposed methods include using recursive partitioning [61, 4], Cox modeling [46], controlled parti-
tioning with significance checks using data splits [39], and several variants [20, 5]. Unfortunately,
systematic analyses of these methods have usually provided unsatisfactory results in real dataset-
tings and in low-signal simulations [51, 31]. We refer the readers to the book [11] (Chapter 8), and
the review papers [51, 31] for further discussion on these methods.
Finally, we note that some researchers have proposed using CATE estimation as a stepping stone
to finding subgroups. Such a strategy was proposed by Foster et al. [24] with their Virtual Twins
method, namely the T -learner with random forests, while Chernozhukov et al. [14] recapitulate
this idea in the context of a broader call to perform inference on features of the CATE function
rather than the function itself. In another line of work, Shahn et al. [59] integrate (linear) CATE
modeling with latent class mixture modeling in a Bayesian framework to allow for treatment effect
heterogeneity in discrete levels. They then use the feature importance from the latent (logistic)
classifier and the posteriors for the CATE, to estimate qualitatively, subgroups with large treatment
effect.
1.2 The PCS framework for veridical data science
As argued in the previous section, obtaining reliable conclusions with respect to heterogeneous
treatment effects is fraught with difficulty. On the one hand, poor signal and weak priors are
prevalent, and on the other hand, missing potential outcomes means that test-set validation is
not directly feasible. Methods validated on simulation studies may not work well for real data
problems since their performance are often misleading. Furthermore, empirical evidence tells us
that the relative and absolute performance of estimation algorithms is highly data and context-
dependent [50].4 Given these problems, it is puzzling to see that much new methodology is being
developed that is detached from solving real data problems.
In this paper, we re-analyzed the 1999-2000 VIGOR study (a 8076 patient randomized clinical
trial), and had to face precisely these challenges. To overcome them, we take advantage of the
recent works on CATE estimation [6, 37, 4, 49, 63] and build on the PCS framework for veridical
data science recently introduced by Yu and Kumbier [66]. As a result, we develop a methodology
called Stable Discovery of Interpretable Subgroups via Calibration (StaDISC) that is generally
3More importantly, investigating subgroups in this manner is particularly sensitive to human failures. It opens the
door to p-value hacking [67], while Gelman has argued that even when researchers try to be honest, they nonetheless
have a hard time accounting for “researcher degrees of freedom” [25].
4In fact, different methods and research groups sometimes reach different conclusions on the same datasets, see
the paper [12] and the references therein.
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applicable beyond this dataset. We now briefly review the PCS framework, before turning to the
overview of our contributions and StaDISC in Section 1.3.
The PCS framework bridges, unifies, and expands on ideas from machine learning and statistics
for the entire data science life cycle. The letters in PCS stand for the three core principles of
data science, namely Predictability, Computability, and Stability. In a nutshell, the PCS frame-
work advocates using both predictability and stability analysis, argued and documented in a PCS
documentation, for reliable and reproducible scientific investigations, thereby providing a way for
bridging Breiman’s Two Cultures [8]. More specifically, predictability emphasizes reality checks for
the modeling stage, by integrating the use of data-driven validation such as out-of-sample testing
favored by machine learning, and that of goodness-of-fit measures that have a rich history in tra-
ditional statistics. Stability, besides encompassing sampling variability, expands to other stability
or robustness concerns of the contingency of modeling conclusions to researcher “judgment calls”.
These calls include the choices made by the researcher at various stages of the data science life
cycle, including data cleaning in addition to the modeling decisions such as model choices and data
perturbations. Computability reflects the need to keep computational feasibility and efficiency in
mind when constructing any modern data analysis pipeline, especially those that subscribe to the
first two principles, which are usually more demanding computationally.
The PCS framework addresses to a certain extent Professor Efron’s concern [21] that machine
learning methods (or pure prediction algorithms) are not ready to be used on scientific problems.5
The PCS framework adds a paramount consideration of stability to predictability and computability
that are hallmarks of machine learning. It guides researchers in validating machine learning and
statistical methods with respect to the specific task they are to be applied and extracting data
conclusions that can be relied upon. As one of us has previously discussed [65], even though 100%
truth is beyond reach, a useful goal is an “accurate approximation for a particular domain, and
relative to a particular performance metric,” which is a more precise articulation of George Box’s
belief that “all models are wrong, but some are useful.”
1.3 Our contributions
This paper makes three main contributions. First, we seek subgroups with demonstrable heteroge-
neous treatment effects in the dataset from the 1999-2000 VIGOR study (a 8076 patient randomized
clinical trial). Enroute, building on the recent CATE literature and the PCS framework, we de-
velop a new methodology, which we call Stable Discovery of Interpretable Subgroups via Calibration
(StaDISC). We provide an overview of this methodology toward the end of this section. Finally,
this paper also serves as the first articulation of the PCS framework in the context of causal in-
ference, with StaDISC providing a template for more informative understanding of heterogeneous
outcomes.
5In Professor Efron’s timely and thought-provoking revisiting [21] of the Two Cultures debate [8], it is argued that
contrasting philosophies on scientific truth is a clear line that separates traditional regression methods from modern
machine learning methods (or pure prediction algorithms). While the former aims at an eternal scientific truth, the
latter is truth-agnostic and instead content to exploit contingent and ephemeral patterns.
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Organization: The rest of the paper is organized as follows. In Section 2, we start with a brief
history of the VIGOR study, and then describe the dataset and data engineering, and splitting
done by us. Section 3 reviews the Neymann-Rubin model briefly with basic notations introduced.
The development of the StaDISC methodology (overviewed below) is carried out in Sections 4
to 6. We conclude in Section 7 with a recap of our results, a discussion of the relevance of our
discoveries in medicine, and discuss several directions for future work with StaDISC. Most of the
figures and tables are deferred to the appendix. Moreover, in accordance with the PCS framework’s
requirement for clear and careful documentation, we provide our code, data cleaning, and statistical
analyses in the form of Jupyter notebooks on GitHub (https://github.com/Yu-Group/stadisc).
Overview of StaDISC: First of all, a given data set (deemed approximately iid) is divided into
a holdout test set STEST and a training set STRAIN (per outcome). For hyperparameter tuning, we
use 4-fold cross validation with the training data STRAIN.
6 For any set of training folds, we refer to
the leftout fold as the corresponding validation fold. The test set is used only once at the final step of
checking the significance of the interpretable subgroups found by our methodology. See Section 2.3
for more details on data splitting and Section 4.1 for the fitting of CATE estimators. With this
set-up at hand, StaDISC can be summarized in three steps: a predictive reality check in Section 4
based on calibration, stability-driven ranking and aggregation of CATE estimators in Section 5, and
finally the CellSearch procedure for finding interpretable subgroups in Section 6. In Section 4, we
introduce a novel calibration-based pseudo-R2 score for CATE estimators denoted by R2C, which
involves placing individuals (in both training and validation folds) into equally-sized bins based
on their predicted CATE value, with quantiles of the predicted CATE distribution on the training
folds as thresholds for the CATE estimators. Using such a binning and the R2C-scores, we show
that 18 popular CATE estimators generalize poorly for the VIGOR data on the validation folds of
the training data. However, we find that certain quantile-based bins (referred to as quantile-based
top subgroups) do generalize well in the sense of having significantly stronger subgroup CATE on
both training and validation folds. This provides the starting point of the next step. In Section 5,
we use the t-statistics of the treatment effect over the quantile-based top subgroups and its stability
over 7 different appropriate data perturbations to rank, screen, and finally average the screened
CATE estimators (the ensemble CATE estimator). Section 6 details the last step of StaDISC,
where we introduce the CellSearch procedure to find a stable and interpretable representation
of the quantile-based top subgroup of the ensemble from the previous step, and then check its
performance on the holdout test set (which was used only for final testing).
As a final overview remark, we note that we use poor performance and good/bad generalization
in a slightly loose sense throughout the paper. We only use the holdout test set at the final stage,
for verifying the CATE estimates of discovered subgroups. Nonetheless, we use the phrase poor
generalization to refer to worse-than-expected-performance, where the performance metric varies
across results, on the validation folds.
6Due to the low signal in data, we decided not to split the data into training and validation sets, and instead use
4-fold cross validation on the training data.
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2 Dataset from the VIGOR study
In this paper, we are interested in finding subgroups of patients that benefit from the treatment in
the dataset from the Vioxx gastro-intestinal outcomes research (VIGOR) study [7]. In the process
of seeking such subgroups, we develop the new StaDISC methodology. In this section, we provide
an overview of this study and the dataset, and also explain our data pre-processing and feature
engineering.
2.1 VIGOR study history and description
The VIGOR study was a randomized head-to-head trial comparing two drugs used to alleviate
pain and inflammation for patients with rheumatoid arthritis: a “new” cyclooxygenase-2 (COX-2)
inhibitor drug Rofecoxib (Vioxx) recently approved and developed by Merck, and Naproxen, a
standard nonsteroidal anti-inflammatory drug (NSAID) already in routine clinical use for many
years. NSAIDs, though effective for treating pain and inflammation, cause serious gastrointestinal
side effects in a small proportion of patients with frequent use. The rationale for the develop-
ment of COX-2 inhibitors, such as Vioxx, was reduced gastrointestinal toxicity as compared with
traditional NSAIDs. Previously conducted short term clinical studies were supportive of this hy-
pothesis although concerns about potential cardiovascular toxicity associated with Vioxx had also
been raised.
Aim of the study: The VIGOR study was designed to provide more conclusive evidence of
the superior gastrointestinal safety of Vioxx. The study was conducted in the years 1999-2000
by Merck with the primary hypothesis that its drug Vioxx would have fewer gastrointestinal side
effects than Naproxen for the treatment of rheumatoid arthritis. The study population comprised
of 8076 patients “with rheumatoid arthritis who were at least 50 years old (or at least 40 years old
and receiving long-term glucocorticoid therapy) and who were expected to require NSAIDs for at
least one year”. This population was known to be at relatively high risk of gastrointestinal side
effects with NSAIDs.7 The patients in the control arm were assigned the drug Naproxen, while the
patients in the active treatment arm were assigned Vioxx.
Details and findings of the study: Patients were followed for a median time of 9 months, and
the primary end point was time to first occurrence of a confirmed clinical upper gastrointestinal (GI)
event defined as “gastroduodenal perforation or obstruction, upper gastrointestinal bleeding, and
symptomatic gastroduodenal ulcers”. The original study report [7] performed a survival analysis
using a Cox proportional hazard model, and estimated the relative risk for patients in the treatment
arm compared with those in the control arm to be 0.5, with a confidence interval of 0.3 to 0.6.8
7However, the study was conducted with a safety monitoring board: an independent committee whose purpose is
to monitor the results of an ongoing trial to ensure the safety of trial participants).
8This estimate and the other estimates reported in this paper are based on an intention-to-treat analysis. The
study also performed per-protocol and sensitivity analyses and obtained similar results.
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The study authors also conducted a subgroup analysis for the GI events, analyzing subgroups
defined by gender, age, nationality, steroids, PUB history (prior history of GI events), and presence
of H. pylori antibodies. The rationale was that certain patients were known to be at increased risk
of GI events, and they wanted to see if the benefit of Vioxx extended to these high-risk patients.
The conclusion from the subgroup analysis was that the risk ratio for every subgroup remained
significant, while differences of the ratios between subgroups were not significant.
However, VIGOR demonstrated that Vioxx was associated with an increase risk of thrombotic
cardiovascular events (henceforth referred to as TC events), an aspect that was not emphasized
in the original report of the study [7]. The study authors suggested that apparent association of
Vioxx with TC events was actually the result of Naproxen preventing TC events. However, placebo
controlled studies confirmed that Vioxx did indeed cause TC events, and this ultimately led to the
withdrawal of Vioxx from the market. We refer the reader to the articles [36, 56] for more context
on the VIGOR study and its consequences thereafter.
Goal of our investigation into the VIGOR dataset: In this work, we perform analysis
for both the GI and TC events. While the GI event was an infrequent event (experienced by
around 2% patients) in the study, the less common TC event (around 0.6% were reported to have
a confirmed TC event) was considered to be more significant medically. Since the earlier works
already established that Vioxx led to an overall decrease in the GI risk but an increase in the cardio
risk on the overall population of the study, an important by-product of this work is finding clinically
relevant and interpretable subgroups of interest for which Vioxx provided a significant decrease in
the risk for the GI event but did not increase the risk for the TC event. Interpretability of the
subgroup, as well as the transparency of the search procedure is important from a clinical view
point, as the doctors can then better justify their choice to favor prescribing the drug for patients
in the discovered subgroup.
We present detailed results both for the GI and TC events throughout this paper, while occa-
sionally deferring some details to the appendix. To perform our analysis, we created a dataset with
the two outcomes—GI and TC event—as discussed above, a treatment indicator, and 16 binary
features. The data processing necessary to create this dataset is the topic of the next section.
2.2 Feature selection and engineering
The VIGOR study collected an extensive range of patient data, including demographic details, prior
medical history, as well as the timing and details of adverse events during the clinical experiment.
From this, we extracted sixteen clinically relevant binary features, which we report in Table 1
together with covariate balance details.
We now describe some of the decisions we took with respect to feature engineering, as well as
the meaning the selected features. The medical history risk factors and drug use information were
all already binary, and were selected by the VIGOR study designers as being medically relevant.
For instance, it is known that use of glucorticoids predisposes patients to GI events in the context
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of concomitant NSAID administration [29]. One feature that deserves special interest is ASPFDA.
This was an indicator for patients in the study who “met the criteria of the Food and Drug
Administration (FDA) for the use of aspirin for secondary cardiovascular prophylaxis but were not
taking low-dose aspirin therapy” [7], and was thought to be an especially strong risk factor for
cardiovascular events. Patients who were taking aspirin therapy were excluded from the study.
On the other hand, some of the demographic and lifestyle risk factors required some engineering.
The goal of the feature engineering was to simplify the data using prior information, so as to avoid
overfitting and to simplify downstream data analysis. While the study collected more precise data
on the patient’s country of residence and their race, in both cases, a single level (“US” and “white”
respectively) contained a large fraction of the data, and we used these to binarize the two features.
We also applied a similar logic to the smoking and alcohol lifestyle risk factors. We used height
and weight information to calculate the body-mass-index (BMI) for every patient, and then used
a threshold value of 30 to obtain an indicator for obesity.9 Finally, we calculated the adjusted age
for every patient (by multiplying their numerical age by the ratio of the life expectancy in the US
to that in their country of residence), and then used a threshold value of 65 to define an indicator
for being elderly.
The dataset was remarkably complete, with only a single patient missing an entry for each
lifestyle risk factor (we filled in this with a 1), while 35 patients were missing entries for either
height or weight, leading to a missing entry for the obesity indicator (we filled this in with a 0).
Furthermore, the features also have weak pairwise correlations except for the fact that the subgroup
with ASPFDA=1 (321 patients) is a subset of that with ASCGRP=1 (454 patients).
2.3 Data splitting
As a known best practice included in the PCS framework, for each outcome, we created a holdout
test set comprising 20% of the individuals, which we did not touch in our further investigations
until the very last stage of our analysis, i.e. when we wanted to verify our results. Because of the
rarity of events for both outcomes, we stratified the split by both the treatment and the outcome si-
multaneously; such a stratification ensures that the outcome remains balanced across the test-train
splits. Let Y denote the binary outcome of interest (GI or TC event), and T denote the treat-
ment indicator. Then such a stratification (implemented as model selection.train test split
function in the sklearn library [53]) is done by first categorizing the study subjects in 4 categories
{{T = 0, Y = 0} , {T = 1, Y = 0} , {T = 0, Y = 1} , {T = 1, Y = 1}}—once with Y denoting the GI
event, and once with Y denoting the TC event. And, then we select a randomly sampled (without
replacement) 20% of the subjects from each category together as the test set STEST, the remaining
subjects form the training set STRAIN.
Also, keeping in mind the rarity of the signals, we do not create an additional validation set, and
instead we use the training data via a 4-fold cross validation, where the folds are split uniformly
at random. For such a split, each fold has around 35 GI events and 11 TC events among the 1615
9https://www.cdc.gov/obesity/adult/defining.html, last accessed on August 11, 2020.
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Covariate (ABBRV) Control No. (%) Treatment No. (%)
Overall population 4029 (49.9) 4047 (50.1)
Demographics
Whether gender is male (MALE=1) 814 (20.2) 824 (20.4)
Whether race is white (WHITE=1) 2752 (68.3) 2764 (68.3)
Whether country is US (US=1) 1750 (43.4) 1748 (43.2)
Whether adjusted age† > 65 (ELDERLY=1) 1172 (29.1) 1136 (28.1)
Whether body-mass-index > 30 (OBESE=1) 1060 (26.3) 1106 (27.3)
Lifestyle
Whether patient smokes ≥ 1 cig./day (SMOKE=1) 1879 (46.6) 1919 (47.4)
Whether patient has ≥ 1 alcoholic drinks/week (DRINK=1) 1045 (25.9) 1053 (26.0)
Prior medical history
of GI PUB events∗ (PPH=1) 317 (7.9) 313 (7.7)
of hypertension (HYPGRP=1) 1168 (29.0) 1217 (30.1)
of hypercholesterolemia (CHLGRP=1) 293 (7.3) 343 (8.5)
of diabetes (DBTGRP=1) 254 (6.3) 240 (5.9)
of atherosclerotic cardiovascular disease (ASCGRP=1) 216 (5.4) 238 (5.9)
indicating use of aspirin under FDA guidelines (ASPFDA=1) 151 (3.7) 170 (4.2)
Prior usage of drugs
Whether used glucocorticoids/steroids (PSTRDS=1) 2253 (55.9) 2244 (55.4)
Whether used Naproxen (PNAPRXN=1) 747 (18.5) 759 (18.8)
Whether used NSAIDs (PNASIDS=1) 3341 (82.9) 3344 (82.6)
Outcomes
Whether GI event occurred (GI=1) 121 (3.0) 56 (1.4)
Whether TC event occurred (TC=1) 18 (0.4) 41 (1.0)
Table 1: Overview of the baseline covariates in the control and treatment arm of the VIGOR study.
†Adjusted age denotes age multiplied by the ratio of the life expectancy in the US to that in the
individual’s country of residence. ∗PUB stands for perforations, ulcers and bleeding.
patients. We note that for a given outcome (say GI event), we use the same 4-fold CV split—referred
to as the original split and denoted as cv orig—for tuning the hyperparameters for all the CATE
estimators via cross-validation. We also use two additional 4-fold cross-validation (random) splits in
several results throughout the paper, and denote them by {cv 0, cv 1}. No hyperparameter tuning
is done on these additional splits, and we simply use the tuned parameters from the cv orig split
for fitting the estimators on different sets of training folds of these additional splits. Note that for
any 4-fold CV split, there are 4 possible pairs of training-validation folds, denoted generically by
STF and SVF respectively. Mathematically, given disjoint folds from one 4-fold CV split, namely
{Sf}4f=1 of the training data STRAIN such that STRAIN = ∪4f=1Sf, the 4-pairs of training-validation
folds are be denoted by {(STF = STRAIN\Sf,SVF = Sf), f = 1, 2, 3, 4}.
3 Review on Neyman-Rubin model and notation
Throughout this paper, we will assume the standard set up for a completely randomized experiment
under the Neyman-Rubin counterfactual framework. We assume that we observe a population of
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Checking Covariate Balance in the VIGOR Dataset
Figure 1: A visual illustration showing the covariate balance, and the outcome imbalance (GI and
TC) between the control and treatment population. The abbreviations are detailed in Table 1, the
number next to the abbreviation (ABBRV) denotes the % of the study size taking value 1 for that
ABBRV in the respective arm. Note that the study size was 8076 total patients, and treatment
and control arms comprise of 4029 (49.9%) and 4047 (50.1%) individuals respectively.
size N , in which the treatment variable T is completely randomized. For each individual i, there
are two potential outcomes: Yi(0) when the individual i is assigned to the control arm Ti = 0, and
Yi(1) when they are assigned to the treatment arm, Ti = 1. The Individual Treatment Effect (ITE)
for individual i is defined as the difference of the two potential outcomes τi = Yi(1) − Yi(0). But
this quantity is unobservable since for each individual we only observe one outcome corresponding
to the arm that they are assigned to, i.e, Yi,obs = Yi(Ti) which we denote by Yi for brevity. For each
individual i, we also observe a vector of covariates Xi ∈ X . As is convention with other research
into heterogeneous treatment effects, we perform inference by assuming that the samples are drawn
i.i.d. from an infinite population.10
We now define the various quantities of interest studied throughout this paper. Let G be a
measurable subset of the feature space X . The average treatment effect (ATE), conditional average
10Note that the standard variance estimates reported using this perspective can be taken as conservative estimates
of the finite-sample variances defined in Neyman’s repeated sampling framework [19].
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treatment effect (CATE) and the subgroup CATE are respectively defined as
ATE : τATE := E [Y (1)]− E [Y (0)] , (1a)
CATE : τ(x) := E [Y (1) X = x]− E [Y (0) X = x] , for any x ∈ X (1b)
sub-group CATE : τG := E [τ(X) X ∈ G] , for measurable subset G ⊂ X , (1c)
where the expectation is taken with respect to the iid draws from the infinite population.
At a high-level, the goal of this work is to provide a systematic framework to find subgroups
G ⊂ X , which (i) include non-trivial fraction of the observed data, (ii) are relevant and interpretable
relevant for the domain problem at hand, and (iii) most importantly have significant sub-group
CATE, i.e., τG has significantly larger magnitude than τATE.
Neyman difference-in-means estimates for finite samples: We will often use the classical
Neyman difference-in-means estimator to provide plug-in estimates for the ATE and sub-group
CATE values. Formally, we denote the two study arms by
(Treatment arm) T := {i ∈ [n] : Ti = 1} and (Control arm) C := {i ∈ [n] : Ti = 0} , (2a)
Throughout this paper, we will abuse notation: for any group G ⊂ X , we will use the same symbol
to refer the subpopulation of individuals that belong to it. This allows us to denote the restriction
of the two arms of the study to the subgroup as follows:
T ∩G := T ∩ {i ∈ [n] : Xi ∈ G} and C ∩G := C ∩ {i ∈ [n] : Xi ∈ G} . (2b)
For a finite set A, let |A| denote the number of elements in the set. With this notation at hand,
the plug-in estimators for the average treatment effect τATE and the sub-group average treatment
effect τG are given by
τ̂ATE =
1
|T|
∑
i∈T
Yi(1)− 1|C|
∑
i∈C
Yi(0), and (3a)
τ̂G =
1
|T ∩G|
∑
i∈T∩G
Yi(1)− 1|C ∩G|
∑
i∈C∩G
Yi(0). (3b)
For randomized experiments, both estimates τ̂ATE and τ̂G are unbiased [60], and standard error
estimates are available for it [33]. On the other hand, the precision of τ̂G degrades as the size of
the subgroup shrinks. For the same reason, a direct difference-in-means estimator for CATE (1b)
is almost never feasible, as for most values of x ∈ X (e.g., when X is continuous, or combinatorially
very large), there might not exist any sample with covariate equal to x.
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4 Calibration as a prediction (reality) check for CATE estimators
Following the Predictability principle of the PCS framework, any statistical model must pass a test
of out-of-sample prediction accuracy before we should have any trust in it. This principle is in line
with the ethos of the scientific method, which correlates the strength of a hypothesis with the rigor
of prior attempts to falsify it [54]. As discussed in Section 1.1, however, no such test currently
exists for CATE models. The missing potential outcomes mean we do not have a plug-in estimate
for any risk function R(τ, τˆ) = E [l(τ(X), τˆ(X))]. Furthermore, unlike R2 and ROC AUC scores,
the proxy loss functions proposed for model choice (see Section 1.1 and the references therein) do
not have interpretable scales.
To mitigate this problem, we develop a prediction accuracy check that can be applied to any
CATE estimator. This check makes use of the ideas from the calibration literature [17, 18, 27], and
while passing the check is not a sufficient condition for a CATE estimator to have good performance,
it is at least a necessary one. Even though our StaDISC approach is motivated by and grounded
in the analysis of CATE estimators fitted to the VIGOR study data, we believe it is a general
methodology useful for other causal inference problems.
The rest of this section is organized as follows. We discuss the 18 CATE estimators used in
our analysis of the VIGOR data in Section 4.1. We then introduce the calibration-based scores for
prediction checks in Section 4.2, and apply it to the CATE estimators trained with VIGOR data in
Section 4.3. Finally, in Section 4.4 we show how despite the poor performance on the overall data,
the CATE estimators have good generalization locally, thereby setting the stage for identifying
subgroups with subgroup CATE significantly larger than ATE in Section 5.
4.1 CATE estimators applied on the VIGOR dataset
We now describe the 18 popular CATE estimators used in this work, 14 of which follow meta-
learner strategies. Descriptions of the meta-learner strategies can be found in [37] and [49]. Here,
we simply list our choices of base learners for each meta-learner. The base learners are all drawn
from a pool comprising lasso, logistic regression, random forest (RF), and gradient-boosted trees
(GB). In our statistical analyses, we used implementations of the former three algorithms from the
scikit-learn package [53] and the XGBoost implementation of the latter [62]. Furthermore, for
code cleanliness, we made use of the meta-learner interface provided by the causalml package [13].
In additional to estimators based on meta-learners, we also considered two versions each of causal
tree [4] and causal forest [63]. The versions differ in terms of their hyperparameter choices. We
used causalml’s implementation of the former. For the latter, we were not able to find a well-
documented python implementation of the algorithm, so we built one around causalml’s causal
tree implementation.
1. S-learners (2 estimators): We used RF and GB as the base learners, denoted by. These are
denoted as s rf and s xgb.
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2. T-learners (4 estimators): We used lasso, logistic regression, RF and GB as base learners.
These are denoted as t lasso, t logistic, t rf and t xgb.
3. X-learners (4 estimators): We used lasso, logistic regression, RF and GB as base learners for
the first stage, and lasso as the only base learner for the second stage. These are denoted as
x lasso, x logistic, x rf and x xgb.
4. R-learners (4 estimators): In the case of randomized experiments, the R-learner requires
a choice of base learner for the conditional expectation of the response with the treatment
variable partialed out, and a choice of base learner for the treatment effect. We use four such
pairs, each member of which was chosen uniformly at random from the base learners (with
logistic regression excluded due to its similarity to lasso). Doing this, we got {lasso, lasso},
{lasso, GB}, {RF, lassso}, and {RF, RF}. These are denoted as r lassolasso, r lassoxgb,
r rflasso and r rfrf.
5. Causal Tree and Causal Forest (4 estimators): We used 2 versions each of the causal tree
and causal forest algorithms, which we have denoted as causal tree 1, causal tree 2,
causal forest 1, and causal forest 2. Each pair of estimators differ in their hyperpa-
rameter choices. Specifically, causal tree 1 and causal forest 1 both use a minimum of
50 samples per leaf node, whereas causal tree 2 and causal forest 2 both use a minimum
of 200 samples per leaf node. All other hyperparameter choices are standard and can be
found in our documentation on GitHub.
Here, we briefly justify our choice of the 18 CATE estimators listed above. First, we chose
our pool of base learners because they are representative of the most popular supervised learning
algorithms in use today, with neural networks omitted because of the poor signal and small size of
the data set. The T -learner framework is perhaps the simplest way of fitting a CATE model and
has been used and studied by many different authors. Using lasso as the base learners was proposed
and analyzed by Bloniarz et al. [6] and Imai and Ratkovic [32]. Meanwhile, [24] proposed using RF
as the base learner. The X-learner [37] and R-learner [49] frameworks have both been used by many
recent works. The former has demonstrated favorable performance over other estimators in data
challenges organized by the Atlantic Causal Inference Conference, while the latter has optimality
guarantees under some assumptions, and has been further supported by some follow up work [58].
We included two S-learner estimators for completion, since all four meta-learner frameworks are
supported by the causalml package. The causal tree [4] and causal forest [63] estimators have
similarly been used in much recent work, with the latter attaining the status of being a benchmark
of sorts for CATE estimation methods in many simulations.
All CATE estimators based on meta-learners had the hyperparameters of their component base
learners tuned via 4-fold CV using cv orig. A common hyperparameter grid was used for each
base learner type, with details deferred to our documentation on GitHub.
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4.2 A calibration-based score for CATE estimators
To develop a reality check scheme for CATE estimators, we now build on the literature of calibration
of probability scores.
A binary classifier is said to be well-calibrated if the class probabilities that it predicts for
each sample point is close to the true class probabilities. This property is desirable in many
situations, such as weather-forecasting, where we would like it to rain on close to 40% of the days
on which a 40% chance of rain is forecast. Unfortunately, machine learning models are often not
naturally calibrated, with neural networks in particular being overconfident in their estimated class
probabilities [27]. Furthermore, because class probabilities are unobserved, we cannot directly train
a model to predict these values using supervised learning. While researchers have proposed various
solutions to this problem, the common theme is to bin the observations by their predicted class
probabilities, and then use the observed class distribution over the bin to obtain plug-in estimates
of the true class probabilities.
The concept of calibration has a long history [17, 18], and it has also been referred to as valid-
ity [41] or reliability [44]. Starting for evaluation of weather forecasts in the 1950s [9], calibration
has been widely used as a generic scheme to compare several forecasters [18]. Related ideas have
been used to calibrate a wide range of methods, including Bayesian models [17], SVMs, boosted
trees, random forests [48, 45], and more recently deep neural networks [27].
Binning via estimated CATE values: We now begin to define our calibration-based predic-
tion accuracy measure for CATE estimators. While our scores—to be defined below—are easy to
interpret, defining them formally requires a bit of notation which we now describe.
Consider the training set STRAIN and let Sf, f = 1, 2, 3, 4 denote its 4-fold (random) CV split.
Fix a fold f and let STF = STRAIN\Sf denote the training folds used to fit the CATE estimator
M : X → R, and let SVF = Sf denote the left-out fold, which we also call as validation fold, for the
estimator M. Let mq denote the q-th quantiles of the CATE estimator M on the training folds of
the data:
mq = min
{
c
∣∣∣∣ #{i ∈ STF : M(xi) ≤ c}|STF| ≥ q
}
, for any q ∈ (0, 1), (4)
where by convention we setm0 = −∞ andm1 =∞. Then given a grid of q-values {q1 ≤ q2 ≤ · · · ≤ qK−1}
in the interval (0, 1), we split the real line into K bins as follows:
m0 < mq1 ≤ mq2 ≤ . . . ≤ mqK−1 < m1.
We use this binning to induce a partition of X into K quantile-based subgroups given by
Gj := Gj(M) =
{
x ∈ X ∣∣ M(x) ∈ [mqj ,mqj+1 ]} for j = 0, 1, . . .K − 1, (5a)
Given a set of individuals S (say, training folds STF or validation fold SVF), let MGj∩S denote the
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mean of the predicted CATE from the estimator M on the subgroups Gj ∩ S :
MGj∩S :=
1
|Gj ∩ S|
∑
i∈Gj∩S
M(Xi), where Gj ∩ S = {i ∈ S|Xi ∈ Gj} , (5b)
Similarly, recall that τ̂Gj∩S denotes the plug-in estimate for the subgroup CATE for the subgroup
Gj .
τ̂Gj∩S :=
1
|T ∩Gj ∩ S|
∑
i∈T∩Gj∩S
Yi(1)− 1|C ∩Gj ∩ S|
∑
i∈C∩Gj∩S
Yi(0). (5c)
Score definitions: With these definitions of the sub-groups, we are now ready to define the
calibration score:
Cal-Score(S; M) :=
K∑
j=1
|Gj ∩ S|
|S| ·
∣∣MGj∩S − τ̂Gj∩S∣∣ , (6a)
where we use absolute difference (and not squared difference) since the scale of the quantities
{MGj∩S, τ̂Gj∩S} is pretty small for our dataset. Nonetheless, it is still hard to interpret the absolute
scale of Cal-Score(M), and hence we normalize these scores by a baseline to define a pseudo-R2
score. More precisely, we consider a baseline calibration-score Cal-Score(S; τ̂ATE), obtained by
replacing the the CATE estimator average MGj∩S with that of the (constant) ATE estimate τ̂ATE
in equation (6a):
Cal-Score(S; τ̂ATE) :=
K∑
j=1
|Gj ∩ S|
|S| ·
∣∣τ̂ATE − τ̂Gj∩S∣∣ . (6b)
With equations (6a) and (6b) in place, we define the R2C score as follows:
R2C(S; M) := 1−
Cal-Score(S; M)
Cal-Score(S; τ̂ATE)
. (6c)
Just like the usual R2-score11, the scoreR2C(S; M) can take any value between (−∞, 1], and a model
can be deemed a good fit if this score is close to 1. We interpret the score as measuring, conditioned
on the partition of the feature space into bins, the degree to which the CATE estimator explains the
variability of the CATE with respect to the partition, in comparison to the best constant model.
Since different models induce different partitions, the scores are not necessarily comparable
across models. Furthermore, similar to how calibrated classification algorithms need not have good
11While R2-score was originally introduced for linear regression, several similar measures have been proposed for
providing an interpretable scale to measure the model fit. The R2 for linear regression takes value in [0,1] for training
data, and (−∞, 1] for test data. Close to 1 value suggests a good fit, and a smaller score implies a poor fit. Note
that unlike the R2 for linear regression, for CATE estimators, the pseudo-score R2C is not guaranteed to take value
in [0, 1] even on the training data, i.e., R2C(STF;M) ∈ (−∞, 1]. Nonetheless, in Fig. 2, we observe that for all the
CATE estimators, this score lies in [0, 1] on the training folds, i.e., R2C(STF;M) ∈ [0, 1].
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prediction accuracy, it is possible for a CATE model to have a good R2C score and yet have poor
overall prediction accuracy for the CATE. Nonetheless, having R2C-scores that are reasonably close
to 1 across a range of data perturbations is necessary albeit not sufficient for the CATE model
to have good prediction performance. Moreover, the variability of the score between the choices
S = STF and S = SVF also provides a check on the overfitting of the CATE estimator.
To conclude, the R2C provides two predictive checks for the CATE estimators. On the one hand,
when R2C(STF; M) is much smaller than 1, we conclude that the estimator M has a poor fit on the
training data. On the other hand, a high value (close to 1) value for R2C(STF; M), and a relatively
lower value (close to 0 or negative) for R2C(SVF; M) would necessarily indicate overfitting of the
estimator M.
4.3 Calibration-based predictive check on CATE estimators for VIGOR dataset
We now compute the scores defined in the previous section for the 18 popular CATE estimators
when applied to the VIGOR dataset. We use the evenly-spaced quantile grid {0.2, 0.4, 0.6, 0.8} and
compute the R2C-scores using the K = 5 bins it induces. We also consider a restricted R2C-score to
measure the predictive performance of the estimators for the bottom-2 bins for the GI event, and
top-2 bins for the TC event. To compute this restricted R2C-score, we simply replace the sum over
the index j ∈ {1, 2, . . . , 5} in equations (6a) and (6b) with j ∈ {1, 2} for the GI event and j ∈ {4, 5}
for the TC event, and then plug this restricted sum in equation (6c).
In the previous section, we described how, given a CATE estimator and a fixed fold f, we obtain
two (restricted) R2C-scores—one on the training folds STRAIN\Sf and one on the validation fold Sf.
Repeating this over 4 folds provides us with 4 pairs of such scores. And iterating over M different
types of CATE estimators yields M × 4 such pairs. Furthermore, if we consider L different 4-folds
splits, we get M × 4× L such pairs of scores.
We trained 18 different CATE estimators for both the outcomes, namely the GI and TC events.
However, after fitting, the following estimators learned a zero CATE function: R-learner with
XGBoost for the GI event, and S-learner with XGBoost, Causal Tree with a particular choice of
hyperparameters, and R-learner with XGBoost for the TC event. Thus, going forward we report
results for the remaining 17 CATE estimators for the GI event and 15 CATE estimators for the
TC event. See Section 4.1 for more details on all the estimators. We now first discuss the details of
scores presented in various plots in Fig. 2 and then discuss the conclusions in a separate paragraph.
Details of Fig. 2: In Fig. 2(a), we provide a scatter plot of R2C(STF,M) (training score) and
R2C(SVF,M) (validation score) for 5 different estimators for each fold of original CV split cv origon
the VIGOR data both for GI and TC events. These estimators are T RF, S RF, X RF, R RFRF
and CF 1 which denote T, S, X, R-learners with random forest as base learners, and (one of the
two) Causal Forest respectively. In addition, in the right two figures in Fig. 2(a), we also provide
the scatter plot of the corresponding restricted R2C-scores (see the first paragraph of this section
for its definition) on the training and validation folds for the 5 estimators and both events.
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Next, to check the stability of our conclusion, we compute these scores for all 17 CATE esti-
mators for the GI event, and all 15 CATE estimators for the TC Eventon all 3 random CV splits
{cv orig,cv 0,cv 1}. That is, we obtain a total of 204 and 180 (training and validation) pairs
of R2C-scores respectively for the GI and TC events. In Fig. 2(b), we plot the histogram of these
scores.
Conclusions from Fig. 2: Inspecting the scatter plots in Fig. 2(a), we see clear evidence of over-
fitting, as the validation fold R2C-scores (computed as R2C(SVF,M) in equation (6c)) are systemati-
cally much smaller, and often negative, than those on the training folds (computed as R2C(STF,M)
in equation (6c)). Furthermore, there is substantial variability across different folds. For instance,
one dot corresponding to S RF for GI events was not even plotted because the validation fold R2C
score exceeded the lower y-limit of the plot. These findings are supported by the histograms in
Fig. 2(b), which show that the mean of the validation fold R2C-scores is in fact a negative number
for both GI and TC events. While we presented histograms of the aggregated scores over all the
CATE estimators, the general behavior was also true when looking at individual CATE estimators.
Next, we also note that the bottom-2-restricted R2C-score for the GI event and top-2-restricted
R2C-score have slightly better generalization since the validation scores are generally positive albeit
with the caveat of larger variability across the training folds. (We revisit this aspect in more detail
in Section 4.4.)
The poor performance on average as well as the high variability of performance both lead us
to be skeptical of the conclusions from any CATE estimator on the VIGOR study data. Here,
we remark that the variability of the scores stems from both fluctuations in the trained model as
well as low SNR in the validation fold (leading to Cal-Score deviating from its expected value).
We remind the reader that in total there are 177 GI events and 59 total TC events, and this fact
implies that for each quantile-based subgroup, we should expect to see around 7.1 and 2.3 GI and
TC events respectively in the validation fold, under the assumption of no heterogeneity. The poor
performance is hence entirely to be expected, and in fact could be a general theme for RCTs, as
they are often sufficiently powered for only computing the ATE.
4.4 Extracting data conclusions that can be relied upon
While we conclude that we cannot trust the CATE models in their entirety, it remains to be seen
if we can isolate data conclusions from them that we can rely on. To this end, we take a closer
look the relative ordering of scores MGj∩S (5b) and τ̂Gj∩S equation (5c) across the quantile-based
subgroups {Gj}5j=1 considered in the previous section. Given the quantile-based definition of the
groups, it is natural to test whether we have
MG1∩S ≤MG2∩S ≤ . . . ≤MG5∩S, (estimator CATEs) and (7a)
τ̂G1∩S ≤ τ̂G2∩S ≤ . . . ≤ τ̂G5∩S, (subgroup CATE estimates) (7b)
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Figure 2: Plots with the calibation-based R2C-scores (6c) for various CATE estimators. (a) Scatter
plot of R2C-scores on the training and validation folds for 5 CATE estimators on the original 4-fold
split cv orig on which hyperparameters were tuned via cross-validation. (b) Histogram of the
R2C-scores on the 12 training and validation folds, 4 each from the 3 different CV splits, namely
{cv orig, cv 0,cv 1} for 17 CATE estimators for GI event, and for 15 CATE estimators for TC
event.
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for a set of individuals S comprising either the training folds or the validation fold. In Fig. 3, we plot
these estimates for two estimators X RF and T RF for the GI event in panel (a) and the TC event
in panel (b) for one set of training and validation folds from the original split. In each plot, the blue
error bars denotes the sample standard deviation estimate for the sample mean MGj∩S computed
from {M(Xi), i ∈ G2 ∩ S}, and the red error bars denote the standard error estimate for τ̂Gj∩STF
given by equation (11b). We observe that generally the model CATE estimates
{
MG1∩S
}5
j=1
are
monotonic for both events on both training folds and validation fold. However, the story with the
plug-in subgroup CATE estimates
{
τ̂Gj∩S
}5
j=1
is—not unexpectedly—mixed. For the GI event,
while these estimates are monotonic on the training folds (S = STF), they are not monotonic
on the validation fold (S = SVF). For the rarer TC event, the estimates
{
τ̂Gj∩S
}5
j=1
are not
even monotonic on the training folds. This non-monotonic behavior is far from unique to the two
estimators presented here. Instead, the plots are representative of what we observe for all other
estimators as well, even when using alternate data splits into training and validation folds.
Pairwise comparisons: To summarize this phenomenon, we do a pairwise comparison of succes-
sive quantile-based subgroups and measure the frequency with which the ordering of their CATE
values generalizes to the validation fold, and summarize our results in Fig. 4(a). More precisely,
for a given estimator M, we define the boolean indicators:
Aj,j+1 = I(τ̂Gj∩SVF ≤ τ̂Gj+1∩SVF) for j = 1, 2, 3, 4. (8a)
We then compute how often we have Aj,j+1 = 1 over the 12 validation folds 4 each from the 3 CV
splits {cv orig,cv 0,cv 1}, and denote this value by Aj,j+1. Finally, we provide a box-plot of the
distribution of the values
{
Aj,j+1, j = 1, 2, 3, 4
}
across all 17 CATE estimators for the GI event, and
15 CATE estimators for the TC event in panel (a) of the Fig. 4. A value close to 1 suggests good
generalization, and conversely, a value close to 0 reflect poor generalization. On the one hand, we
see that the pairwise ordering does not generalize well for most pairs of successive quantile-based
subgroups as the frequency of generalization Aj,j+1 concentrates around values ≤ 0.5 for j = 2, 3, 4
for the GI event, and j = 1, 2, 3 for the TC event. On the other hand, we see that values of A1,2
for the GI event, and those of A4,5 for the TC event are pretty close to 1 (we present more precise
numerical values in Table 6.) This observation suggests that the ordering does generalize well
for the subgroup with the strongest negative treatment effect for the GI event, and the strongest
positive treatment effect for the TC event.
Investigating the quantile-based “top” subgroups: We call the subgroups induced by G1
for the GI event, and G5 for the TC event, the quantile-based top subgroup. Note that each subgroup
is specific to a choice of estimator, a choice of training-validation split, and a choice of quantile-grid.
To further analyze the good generalization of ordering for these top subgroups, we also compare
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Figure 3: Investigating the monotonicty trend (equation (7)) for two CATE estimators X RF and
T RF on one set of (3) training folds and (1) validation fold of the original 4-fold split cv orig, for
(a) the GI Event, and (b) the TC Event.
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them to the other quantile-based subgroups via two boolean variables as follows:
for GI event: A1,min := I(τ̂G1∩SVF = min
j
τ̂Gj∩SVF), and (8b)
for TC event: A5,max := I(τ̂G5∩SVF = max
j
τ̂Gj∩SVF). (8c)
We report the distribution of the frequency of generalization A1,min (mean computed over the 12
validation folds) across the 17 CATE estimators for the GI event, and A5,max across the 15 CATE
estimators for the TC event as the rightmost entry of the corresponding figure in Fig. 4(a). The
plots show that, on the validation fold, the quantile-based top subgroup has the strongest treatment
effect 90% of the time for the GI outcome, and about 80% of the time for the TC outcome.
Next, to better investigate the performance of quantile-based top subgroups, we compare these
top subgroups directly against their complement, reporting the results in Fig. 4(b). In this plot,
we also vary the q-value threshold used to define the quantile-based top subgroup. In particular,
we consider groups of the form
G˜q = {x ∈ X |M(x) ∈ (−∞,mq]} (9)
where mq denotes the q-th quantile of the CATE estimator M on the training folds (see equation (4)
for the mathematical expression). Note that with this notation, G˜cq = {x ∈ X |M(x) ∈ (mq,∞}. In
simple words, the subgroup G˜q is based on the quantile range [0, q], and its complement subgroup
G˜cq is based on the quantile-range [q, 1]. Then we check the ordering for between these subgroups
via the following boolean indicators:
Bq = I
(
τ̂
G˜q ∩ SVF ≤ τ̂G˜cq ∩ SVF
)
, for
q ∈ {0.1, 0.2, . . . , 0.5} for GI eventq ∈ {0.9, 0.8, . . . , 0.5} for TC event. (10)
Note that the subgroup of interest is Gq for the GI event and G
c
q for the TC event. Moreover,
in this new notation, the earlier subgroups (from Fig. 4(a)) would be represented as G1 = G˜0.2
and G5 = G˜
c
0.8. We notice that the ordering (10) holds much more frequently (compared to the
pairwise ordering in Fig. 4(a)). We also note from this figure that q = 0.2 and q = 0.8 provide the
best generalization performance for the GI and TC events respectively.
In summary, we have found that at least some of the CATE estimators yield quantile-based top
subgroups that have subgroup CATE that is demonstrably stronger than that of the rest of the
population. Thus, in the following sections, we use these quantile-based top subgroups, namely the
subgroups {Gq, q = 0.1, 0.2, . . . , 0.5} for the GI event, and
{
Gcq, q = 0.9, 0.8, . . . , 0.5
}
for the TC
event for further analysis.
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Figure 4: Box plots for pairwise comparisons of the subgroup CATE estimates for the 5 quantile-
based subgroups based on the quantile grid {0.2, 0.4, 0.6, 0.8}. The boxplots in panel (a), denote the
distribution for the mean fraction Aj,j+1 (8a) (where the mean is computed over the 12 validation
folds, 4 each from the 3 random CV splits {cv orig,cv 0,cv 1}) across various CATE estimators,
for the GI event on the left, and TC event on the right. In addition, we also show the boxplot
of the distribution of the boolean variables A1,min (8b) for the GI event, and A5,max (8c) in the
rightmost column of respective plot. In panel (b), we provide boxplots for the distribution of the
mean value of boolean indicators {Bq (10) across all CATE estimators, for q ∈ {0.1, 0.2, . . . , 0.5}
for the GI event, and q ∈ {0.9, 0.8, . . . , 0.5} for the GI event, where the mean is computed over the
and the distribution is plotted across all the CATE estimators. Refer to Table 6 for estimator-wise
results.
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5 Stability-driven ranking and aggregation of CATE estimators
Based on the discussion at the end of the last section, we believe that we can use a sub-collection
of the CATE estimators to find subgroups with highly negative (in the case of the GI outcome)
or positive (in the case of the TC outcome) subgroup CATE, in the form of a quantile-based top
subgroup. This observation brings us back to the question of estimator screening and choice: We
seek to define a more stringent predictive test, and furthermore, out of all CATE estimators we
considered, we would like to select those that are able to give us the best subgroups. While the
overall goal of StaDISC is to find subgroups that are both statistically significant and interpretable,
we focus in this part of paper on selecting estimators that yield the most significant subgroups, and
only address interpretability in Section 6.
5.1 Comparing estimators using t-statistics
We compare different CATE estimators using the statistical significance of their quantile-based top
subgroup, measured via using standardized scores, namely t-statistic. Given a subgroup G, the
corresponding t-statistic is given by:
TG :=
τ̂G − τ̂ATE√
V̂ar(τ̂G − τ̂ATE)
, (11a)
where the variance of τ̂G− τ̂ATE is estimated by considering that the estimators τ̂G and τ̂ATE admit
a joint distribution. We derive in Appendix A that the variance estimate is given by
V̂ar(τ̂G−τ̂ATE) =
(
1− |G ∩C||C|
)2
· V̂ar
[
Y (0)
∣∣G ∩C]
|G ∩C| +
(
1− |G ∩T||T|
)2
· V̂ar
[
Y (1)
∣∣G ∩T]
|G ∩T|
+
( |Gc ∩C|
|C|
)2
· V̂ar
[
Y (0)
∣∣Gc ∩C]
|Gc ∩C| +
( |Gc ∩T|
|T|
)2
· V̂ar
[
Y (1)
∣∣Gc ∩T]
|Gc ∩T| , (11b)
where for a given set A ⊂ S, the quantity V̂ar [Y (t) ∣∣ A] denotes the sample variance:
V̂ar
[
Y (t)
∣∣A] = 1|A| − 1 ∑
i∈A
Yi(t)− 1|A|∑
j∈A
Yj(t)
2 for t = 0, 1. (11c)
Note that the estimator (11b) is an unbiased estimator of the variance of τ̂G− τ̂ATE. In this paper,
we deliberately choose not to use p-values to report the results, so as to avoid their susceptibility to
misinterpretation. For interested readers, however, we mention the mapping between p-values and
t-statistic (T). The t-statistics presented throughout this work can be associated with one-sided
p-values. In particular, a negative t-statisticwith magnitude 1.65, 1.96, and 2.33 can be mapped
to a left one-sided p-value of 0.05, 0.025 and 0.01 respectively. The same mapping exists between
positive t-statistics and right one-sided p-values.
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5.2 Defining appropriate perturbations
In order to guard against spurious and unreliable discoveries, the Stability principle of the PCS
framework requires conclusions to be stable to reasonable or appropriate perturbations at various
stages of the data science life cycle. These include modeling and data perturbations familiar to
statisticians which are appropriate under the Neyman-Rubin model assumptions, and also “judg-
ment call” perturbations where we reproduce or at least approximate the conclusions that would
have been reached had various contingent choices been made differently. Examples of these choices
include those made during data cleaning and feature engineering.12
As mentioned earlier in the paper, we have used a random CV split in order to fit and analyze
our CATE models for the VIGOR data. In line with our prior discussion, we do not just evaluate
each estimator based on the 3 CV splits {cv orig,cv 0,cv 1}, but also perform concurrent analyses
of the estimator fitted and validated using four-fold splits of the data under 4 additional pertur-
bations. Overall, we denote the set of all 7 perturbations by {cv orig, cv 0, cv 1, cv time,
elderly 60, overweight, pert outcome}, where the 3 (random) CV splits {cv orig,cv 0,cv 1}
have already been used multiple times in the previous results of our paper. For completeness and
to put them in context here, we revisit them while introducing the new perturbations {cv time,
elderly 60, overweight, pert outcome} that we make use of in our subsequent analysis of the
VIGOR dataset. We remind the reader that for each perturbation, we perform the same 4-fold
split for all the CATE estimators. Moreover, we continue to use the tuned hyperparameters from
cv orig for all other perturbations.
Sampling perturbations (cv 0, cv 1, cv time): The additional CV (random) splits {cv 0,
cv 1}, used earlier and also in the sequel, help to account for sampling variability and are pretty
commonly used in statistics and machine learning. Nonetheless, we also share Efron’s concern
that the use of random splits [21] does not play well with possible covariate shift, and may lead
researchers to be overly optimistic about conclusions that do not have external validity. To address
this, we also split the training data into four equally-sized folds by binning based on enrollment-
time, denoted by {cv time}. This simulates possible variability in the sample population due to
human choices (i.e. the date of the RCT)13, and can also be seen more generally as making use of
an a priori irrelevant variable to create heterogeneous folds and thus penalize ephemeral predictors.
Feature engineering perturbations (elderly 60, overweight, pert outcome): We use al-
ternative thresholds to create perturbed versions of the ELDERLY and OBESE features. Instead
of thresholding the adjusted age at 65, we create an ELDERLY 60 feature by thresholding it at 60,
and instead of thresholding BMI at 30, we instead threshold it at 25 to define the feature OVER-
WEIGHT. In this way, we create two perturbed datasets, denoted by {elderly 60, overweight}.
12This concern is similar to that expressed by Gelman in his influential paper on The Garden of Forking Paths [25].
13In fact, such a time-based split would be even more relevant for studies based on RCTs that are online in nature,
meaning that during the trial, results from earlier stages of the trial are used to guide whether the trial would be
continued further or concluded.
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Finally, for both the GI and TC outcomes, the VIGOR study recorded for each patient both
whether an event occurred, and also whether the occurred event was confirmed (meaning that it
met the stringent criteria of an independent panel). In the original study, and thus far in our
paper, we have used the confirmed events as the response of interest, but we now make use of the
unconfirmed events to create a new response variable tracking all events. This increases the number
of GI events from 177 to 190 and the number of TC events from 59 to 84. Replacing the original
responses with these one creates a further perturbed dataset for each outcome, which we denote
by {pert outcome}. For the three perturbations {elderly 60, overweight, pert outcome}, we
use the original 4-fold split cv orig of the patients (albeit with the perturbed features or outcomes
in the data).
Performing our analyses on these perturbed datasets reveals to us what would have happened
had we, or the original study authors, made different contingent decisions in feature engineering
or problem formulation. Although models fit on these datasets no longer have exactly the same
meaning as those fit on the original data, we still expect the estimators that perform well on the
original data to also perform well on these perturbed datasets.
5.3 Ranking and aggregation of CATE estimators
In this section, we first rank the CATE estimators based on their performance across all data
perturbations elaborated in the previous section. And, then we select the estimators that are
ranked in Top-10 estimators across all the perturbations. Finally, we build a single “ensemble CATE
estimator” by taking a simple average (equal weights) of all the selected CATE estimators. Quantile-
based top subgroups of the ensemble estimator form the starting point of finding interpretable
subgroups in Section 6. We now describe the details of our ranking procedure.
Mean t-statistic per data perturbation: For a CATE estimator M, for each data perturbation
D ∈ {cv orig, cv 0, cv 1, cv time, elderly 60, overweight, pert outcome}, we compute
the mean t-statistic averaged across all quantiles across the corresponding 4 validation folds. In
our notation, for the GI event, this mean t-statistic is given by
TGI(D) =
1
20
∑
q∈Q
∑
SVF∈F
T
G˜q ∩ SVF where Q = {0.1, 0.2, . . . , 0.5} ,F = {Sf, f = 1, 2, 3, 4} , (12a)
where the quantile-based top subgroup G˜q was defined in equation (9). Moreover, we remind the
reader that the quantiles that define the subgroup G˜q (see equations (4) and (5a)) are computed
based on the CATE estimates from the fitted M on its training folds STF = STRAIN\SVF. On the
other hand, the t-statistic on the RHS of equation (12a) is computed on the validation fold SVF.
For the TC event, the corresponding mean t-statistic is given by
TTC(D) =
1
20
∑
q∈Q
∑
SVF∈F
T
G˜cq ∩ SVF
where Q = {0.9, 0.8, . . . , 0.5} ,F = {Sf, f = 1, 2, 3, 4} , (12b)
27
We report the mean t-statistic T(D) for each CATE estimator and all 7 data perturbations in
Table 2(a) for the GI event, and Table 2(b) for the TC event. We also provide a visual summary
of the 7 mean t-statistic for each estimator in the form of boxplot in Fig. 5 in panel (a) for the GI
event, and panel (b) for the TC event.
Ranking the CATE estimators: Next, for each category D, we rank the mean t-statistic from
lowest to highest for the GI event, and highest to lowest for the TC event. In accordance with
the Stability principle of the PCS framework, we screen for estimators that perform well across
perturbations, and thereby select all estimators that rank in Top-10 across all data perturbations
D. We provide the visual illustration of these ranks also in Fig. 5 for the two events. In fact, the
estimators in the Fig. 5 are sorted based on their worst rank across the perturbations. This criterion
selects (i) 2 T-learners and 4 X-learners {t lasso, x rf, t rf, x xgb, x lasso, x logistic} for the GI
event, and (ii) 1 S-learner, 3 T-learners, and 1 X-learners {s rf, t lasso, t rf, x xgb, t logistic} for
the TC event. The selected list can also be verified by a simple inspection of the rank plots from
Fig. 5.
Final step before interpreting: Keeping in mind the computational aspects of the next step
(finding interpretable subgroups), and to increase stability, we decided to build an ensemble CATE
estimator by using a simple average of the selected CATE estimators. Moreover, we also investi-
gate the performance of the quantile-based top subgroups for this ensemble, and report the mean
t-statistic across the 12 validation folds from {cv orig,cv 0,cv 1} for G˜q (9) for the GI event,
and G˜cq for the TC event in Table 3. We report the standard deviation of the t-statistic across
these folds in parentheses. In addition, we also report the mean percentage overlap computed
pairwise across the entire training set STRAIN for the 12 ensemble estimators, 4 each from the 3
CV splits {cv orig,cv 0,cv 1}. We observe that for the GI event the subgroups corresponding to
q ∈ {0.2, 0.3} have relatively higher T, and for the TC event q ∈ {0.9, 0.8} are the top 2 choices.
The trends for overlap are as expected, with the increase in size of the group, the overlap generally
increases; and remains > 70% across all choices. In the next section, we discuss our methodology to
find an interpretable representation of the quantile-based top subgroups using the ensemble CATE
estimator. As a final decision before that step, we choose the groups G˜0.2 and G˜0.3 for the GI event,
and G˜c0.9 for the TC event, based on their high t-statistic. We also include the group G˜
c
0.8 for the
TC event keeping in mind the fact that the TC event is very rare, and thus the low signal in the
subgroup Gc0.9 (having only 10% of the training data) may become a bottleneck for any reasonable
inference task.
6 Finding interpretable subgroups
The next and final step of our investigation is to make our findings interpretable. Recall that the
end goal in investigating the heterogeneous treatment effects in the VIGOR study is to inform
treating physicians which subgroup of patients are likely to benefit from the reduced risk of GI
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Perturbation D cv orig cv 0 cv 1 cv time elderly 60 overweight pert outcome
Estimator M TGI(D)
t lasso -1.27 -1.79 -1.52 -1.36 -1.36 -1.02 -1.24
x rf -1.24 -1.84 -1.37 -1.58 -1.40 -1.22 -1.38
t rf -1.25 -1.62 -1.39 -1.34 -1.34 -1.24 -1.43
x xgb -1.16 -1.80 -1.44 -1.45 -1.31 -1.11 -1.10
x lasso -1.23 -1.88 -1.49 -1.33 -1.28 -1.04 -1.15
x logistic -1.31 -1.86 -1.39 -1.26 -1.31 -0.96 -1.06
r lassorf -1.26 -1.34 -1.36 -1.56 -1.63 -0.95 -0.96
t logistic -1.33 -1.72 -1.56 -1.14 -1.27 -1.17 -1.19
r rfrf -1.24 -1.45 -1.33 -1.51 -1.50 -1.00 -0.84
causal forest 2 -1.00 -1.32 -1.39 -1.23 -1.22 -0.94 -0.92
t xgb -1.02 -1.73 -1.18 -1.31 -1.38 -1.01 -1.34
r lassolasso -1.10 -1.76 -1.25 -1.19 -1.19 -1.07 -0.76
causal forest 1 -0.97 -1.26 -1.25 -1.10 -1.07 -0.84 -1.32
s xgb -0.95 -1.35 -1.57 -0.99 -1.02 -0.90 -0.99
causal tree 1 -0.67 -1.22 -0.98 -0.50 -0.66 -0.80 -0.46
causal tree 2 -1.07 -0.87 -0.72 -0.96 -1.09 -0.88 -0.64
s rf -0.78 -1.44 -0.81 -1.19 -1.33 -0.59 -1.12
(a) GI Event
Perturbation D cv orig cv 0 cv 1 cv time elderly 60 overweight pert outcome
Estimator M TTC(D)
s rf 0.96 1.29 1.17 1.42 1.29 1.05 1.26
t lasso 1.06 1.16 0.99 1.02 1.10 1.07 1.14
t rf 1.10 1.19 0.90 1.25 1.24 1.18 1.45
x xgb 1.01 1.15 0.89 1.03 1.08 1.04 1.11
t logistic 1.10 1.16 1.03 1.17 1.17 0.93 1.02
x logistic 0.97 1.11 0.87 0.94 1.14 0.92 1.01
x rf 0.90 1.11 0.88 0.91 1.09 0.99 1.02
x lasso 0.92 1.13 0.80 0.90 1.10 0.94 1.03
t xgb 0.66 1.06 0.92 1.26 0.95 0.66 1.26
r rfrf 0.86 1.12 0.70 1.01 0.88 0.96 0.97
r lassorf 0.79 1.14 0.75 0.93 0.86 1.03 0.81
r lassolasso 0.81 1.01 0.65 0.61 1.01 0.84 0.98
causal tree 2 0.67 0.88 0.84 -0.33 0.64 0.49 1.28
causal forest 1 0.93 1.14 0.96 0.74 0.58 0.64 0.71
causal forest 2 0.46 0.72 0.87 0.55 0.56 0.96 1.12
(b) TC Event
Table 2: Estimator- and perturbation-wise t-statistic TGI(D) (12a) for the GI event in panel (a),
and TTC(D) (12b) for the TC event in panel (b). In each column the best (lowest for GI event,
highest for TC event) t-statistic is highlighted in bold. The order of the estimators in panel (a)
and (b) is the same order as that in Fig. 5(a) and Fig. 5(b) respectively.
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Figure 5: Box plots of the rank and value of mean t-statistic scores TGI(D) (12a), and TTC(D) (12b),
where the distribution is over the 7 data perturbations D ∈ {cv orig, cv 0, cv 1, cv time,
elderly 60, overweight, pert outcome}. Here rank for the mean t-statistic score is computed
per perturbation D, and all CATE estimators are ranked lowest to highest for the GI event, and
highest to lowest for the TC event. The estimator- and perturbation-wise numbers for both panels
are reported in Table 2.
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Bottom quantile GI Event
based subgroup G˜q TG˜q Overlap
q = 0.1 -1.32 (0.20) 73%
q = 0.2 -1.58 (0.19) 77%
q = 0.3 -1.47 (0.16) 82%
q = 0.4 -1.02 (0.12) 83%
q = 0.5 -0.81 (0.12) 87%
Top quantile TC Event
based subgroup G˜cq TG˜cq Overlap
q = 0.9 1.28 (0.22) 77%
q = 0.8 1.03 (0.12) 75%
q = 0.7 0.85 (0.12) 77%
q = 0.6 0.71 (0.09) 79%
q = 0.5 0.57 (0.13) 82%
Table 3: t-statistic for different quantile-based top subgroups of the ensemble CATE estimator.
“Overlap” column reports the average % pairwise overlap between the 12 quantile-based top sub-
groups on the entire training data, namely G˜q ∩STRAIN for the GI event, and G˜cq ∩STRAIN for the
TC event. The 12 subgroups correspond 4 each to the 3 CV splits {cv orig, cv 0, cv 1}.
events, without simultaneously incurring an increased risk of TC events. Physicians may then
favor prescribing the drug for patients in this subgroup. In situations involving high stakes decision-
making such as this one, decision-makers are usually not comfortable with black-box decision rules,
but instead ideally require rules to be transparent and interpretable, so as to align them with their
own knowledge base, and justify them to patients and regulators.
6.1 Interpreting using “cells”
In the work by Murdoch et al. [43], one of us has argued that a key element of interpretability is the
notion of relevance. Interpretations need to provide “insight for a particular audience into a chosen
domain problem.” Since clinical decision rules usually take the form of decision trees, a decision
tree is the gold standard for our problem at hand. Each leaf of a decision tree constitutes a subset of
the feature space defined by constraining the values of the features occuring along the root-to-leaf
path. We call such a subset of a feature space a cell14, and propose to make our quantile-based
top subgroups interpretable by approximating it with a union of a few cells, which we call a cell
cover.15
Two remarks are in order. First, we find empirically that no single cell gives a good approxima-
tion of quantile-based top subgroups, so we require the additional flexibility of a union of multiple
cells. Furthermore, reporting a union of cells is more flexible than reporting a decision tree, because
it is not always possible to construct a tree with a given collection of cells as its leaf nodes.16 Sec-
ond, by focusing on cells, we recognize the importance of interactions, or in other words, nonlinear
dependence of treatment effect on the covariates. Chernozhukov et al. [14] proposed interpreting
quantile-based top subgroups by estimating the differences in the “observed characteristics” be-
tween the quantile-based top subgroup and the subgroup that is defined to be least affected by the
treatment, but this only considers the marginal importance of each feature.
14This term is motivated by the geometric interpretation of such subsets as subcubes of the hypercube that
comprises the entire feature space.
15One may also think of this as a disjunction of conjunctions.
16For instance, leaf nodes will always involve the feature that splits the root node.
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6.2 Cell-search methodology
In this section, we demonstrate a general framework for how to search for a cell cover that con-
tains most of the individuals in the quantile-based top subgroup, but does not include too many
individuals from outside it.
Feature selection: In order to make the subsequent steps of cell search more computationally
tractable, we start by selecting up to 10 features from the original list of 16 features. To do this, we
compute feature importance scores in two different ways. (i) Following Chernozhukov et al. [14],
we make use of the difference between the mean of the feature values over the quantile-based top
subgroup and that over its complement. We refer to this score as the “Logistic” feature importance
score. (ii) We train a logistic classifier to predict membership in the quantile-based top subgroup,
and make use of the coefficients. In either case, we normalize so that the absolute values of the
scores sum to one. We refer to this score as the “Difference” feature importance score. We compute
these two types of scores for the ensemble CATE estimators’ quantile-based top subgroups selected
at the end of Section 5.3, namely G˜0.2 and G˜0.3 for the GI outcome, and G˜
c
0.9 and G˜
c
0.8, across the
twelve random training-validation splits ({cv orig, cv 0, cv 1}). For each outcome, we average
the feature importance scores across the different splits as well as both choices of the quantile-based
top subgroups. The final results are shown in Fig. 6.
Ranking the 16 features according to the two measures of feature importance, we select the
features that rank among the top 8 under either measure. Note that we choose to make use of both
feature importance measures because they have different meanings: While the first score measures
the marginal importance of each feature, the second measures its conditional importance. However,
the choice of “top 8” was also selected keeping in mind the fact that the top features for the two
measures have a high overlap, and we end up selecting 9 and 10 features respectively for the GI
and TC events listed (alphabetically) below:
GI event: CHLGRP, HYPGRP, PNAPRXN, PNSAIDS, PSTRDS, PPH, ELDERLY, OBESE, and WHITE
TC event: ASCGRP, ASPFDA, CHLGRP, PPH, US, ELDERLY, MALE, OBESE, SMOKE, WHITE
Readers may refer to Table 1 to remind themselves about the definitions of all the features.
Iterative procedure: We now describe the CellSearch procedure for finding the cell cover for
a quantile-based top subgroup one cell at a time, with Fig. 7 also providing a pictorial explanation.
For clarity, we introduce some notation, denoting the quantile-based top subgroup by Gtop, and
the cell found at the i-th step by Ci. For GI event Gtop takes the form G˜q, and for the TC event
G˜cq for suitable choices of q. As before, we will abuse notation, using these symbols to refer to
the subgroups and cells as subsets of the feature space, as well as the subpopulation of individuals
that belong to them. At the first step, we consider every possible cell C defined with m features or
less, where m is a user-specified tuning parameter, and compute its “true positive” (TP) and “false
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Figure 6: Mean feature importance scores for the quantile-based top subgroups from the ensemble
CATE estimator. Best seen in color. We plot both the scores next to each other for each feature
with the order (top, bottom) = (logistic, difference), but separately for each outcome. The blue
bars and red bars respectively denote the “Logistic” and “Difference” feature importance scores
described in the text.
positive” (FP) values with respect to Gtop as follows:
TP(C,Gtop) := |C ∩Gtop| , and FP(C,Gtop) :=
∣∣C ∩Gctop∣∣ .17 (13)
Moreover, let ∆(C,Gtop) := TP(C,Gtop)− FP(C,Gtop) denote the difference of these values.
We rank the cells based on their difference score ∆(C,Gtop), but instead of simply picking the
cell achieving the largest positive value ∆max, we first create a candidate list of cells for which
∆(C,Gtop) ≥ max(0,∆max + 0.95 |Gtop|), remove from cells any that are sub-cells18 of other cells
on this list, and then choose one of remaining cells uniformly at random. The returns on adding
this layer of complexity are to favor simpler, more interpretable cells, and also (by running the
procedure multiple times) to discover if two or more cells have comparable performance.19
In each subsequent step of the algorithm, to find the next cell in the cell cover, we first remove
from the study population all individuals belonging to the cells already found, and then repeat the
above process. More rigorously, suppose cells C1, . . . ,Ci−1 have already been determined. The true
18We say that Cell A is a sub-cell of Cell B if it is contained in Cell A when both are though as subsets of the
feature space.
19A user may wish to simply follow the greedy procedure.
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(a) Cover found by CellSearch (b) Illustration of one step of CellSearch
Figure 7: A simplified illustration of CellSearch methodology for finding a cell-based cover for a
given (quantile-based) subgroup.
and false positive scores are now defined by
TP(C,Gtop;∪i−1j=1Cj) :=
∣∣∣C ∩Gtop\ ∪i−1j=1 Cj∣∣∣ , and FP(C,Gtop;∪i−1j=1Cj) := ∣∣∣C ∩Gctop\ ∪i−1j=1 Cj∣∣∣ ,
(14)
while ∆max and the threshold are also modified accordingly. Finally, the procedure terminates
if ∆max at any iteration is less than or equal to 0 or if the number of iterations has reached a
pre-specified threshold (default value 3).
Aggregating results over multiple runs: In accordance with the Stability principle, we run
CellSearch multiple times, and check whether the same cell cover is found. In our case, we ran
it five times on each top quantile subgroup arising from 12 random training-validation splits, for a
total of 60 runs. While the cell cover did not turn out to be stable, we found that certain cells or
their sub-cells frequently re-appeared within each run. We thus turn our focus to individual cells,
and aggregate the results over the multiple runs, calling this procedure StabilizedCellSearch.
To describe how we aggregate the results, we first use B to denote the collection of all 60 runs,
and for each run b ∈ B, we let Cb denote the cover returned by the procedure, while the collection
of all cells found is denoted C := ∪b∈BCb. For each cell C ∈ Cb, we define its stability score as
follows:
Stab(C) =
1
|B|
∑
b∈B
∑
C′∈C
1(C′ ∈ Cb and C′ is sub-cell of C) |C
′|
|C| . (15)
This score measures how frequently cell C and its proper sub-cells are found across the different
runs, with each occurrence weighted by the relative size of the sub-cell.
Finally, we rank the cells according to their stability scores, and output those for which the
score exceeds a user-defined threshold. In our case, we chose the threshold to be 1/3 which results
in finding 3 cells each for the GI and TC outcomes. We discuss these cells in the next section, while
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the full results obtained by running StabilizedCellSearch on the VIGOR data with respect to
both the GI and TC outcomes is shown in Table 7.
6.3 Discussion of cells found and performance on test set
In this section, we discuss the statistical significance of the cells found for both GI and TC outcomes.
First, we list the top 3 cells found for each outcome, where detailed results for top 20 cells (sroted
by Stab-scores) are reported in Table 7. For the GI outcome, the top 3 stable cells are:
(i) C1: Patients with prior history of GI Event denoted as {PPH=1},
(ii) C2: patients who (self) reported a prior (to the experiment) usage of steroids, and a history
of hypertension denoted as {PSTRDS=1, HYPGRP=1}, and
(iii) C3: Elderly patients who reported a prior usage of steroid drugs denoted as
{PSTRDS=1, ELDERLY=1}.
For the TC outcome, they are:
(i) C˜1: Patients for which use of Aspirin has been indicated as per FDA guidelnes {ASPFDA=1},
(ii) C˜2: Male elderly patients {MALE=1,ELDERLY=1}, and
(iii) C˜3: Patients that have reported prior history {ASCGRP=1}.
For further details on the features appearing above, please refer back to Section 2.2. In Fig. 8, we
plot the overlap between these cells.
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Figure 8: Overlap matrix for final discovered cells on the training data STRAIN. For panel (a) the
data split is stratified on the treatment indicator and the GI outcome, and that for (b) is stratified
on on the treatment indicator and the TC outcome. For instance, the number 82 for the entry
corresponding to C1 and C2 in panel (a) represents that the two cells had 82 patients in common
on the training data.
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Conclusions from Fig. 8: As can be seen in Fig. 8(a), there is little to moderate overlap among
the cells C1 and C3, which shows that they are meaningfully different. On the other hand, there
is significant overlap among the cells C˜1, C˜3 in Fig. 8(b). In particular, C˜1 is a subset (but not a
sub-cell) of C˜3. The reason we report both cells is because of the suspected multi-scale nature of
treatment effect variation for the TC outcome, with C˜1 found more often for q = 0.9, and C˜3 found
more often for q = 0.8.
We now compute and report several quantities for each of these 6 cells, finally making use of
the holdout test dataset (20% of the study size) for the very first time. For cells C1,C2 and C3, as
well as the union ∪3j=1Cj of these 3 cells, the results are reported in Table 4. Similar results for the
cells C˜1, C˜2, and C˜3 and their union ∪3j=1C˜j are reported in Table 5. We now discuss the results
from Tables 4 and 5 one by one.
Results from Table 4: In the first three rows of Table 4, we examine the subgroup treatment
effect for these cells with respect to the GI outcome. In the second and third columns, we report
two versions of the Neyman estimate for the cell CATE τ̂C∩S, one computed on the training set
STRAIN as well as one computed on the test set STEST. Likewise, in the next two columns, we
report the t-statistic TG∩S, one computed on the training set STRAIN, and on the test set STEST.
Finally, in the last column with header †SVAL, we report the mean (and standard deviation in
parenthesis) of the t-statistics T computed on the 12 different folds of STRAIN from the 3 random
CV splits {cv orig, cv 0, cv 1}. Overall, the test set results are promising, with test set CATE
estimates being much more negative than the estimated ATE, and comparable to their training
set counterparts. While we do not report p-values because they can be easily misunderstood, we
note that the test set t-statistic values for the GI outcome are C3, and the union ∪3j=1Cj , are both
significant at the 0.025 level for a one-sided z-test
The starting point of our investigation with VIGOR dataset was the hope to identify a subgroup
for which Vioxx simultaneously has a strong negative treatment effect for GI risk and a low positive
treatment effect for TC risk. Consequently, in the last three rows of Table 4, we report the treatment
effect results for the cells {Cj}3j=1 and their union, with respect to the TC outcome. While C2 and
C3 experience increased TC risk, C1 = {PPH = 1} in fact shows reduced TC risk, which makes it
especially promising for further clinical investigation. We note that for the TC outcome we report
the CATE estimates and the t-statistic on the entire data as this outcome had no role to play in
the entire StaDISC pipeline with the GI outcome, and hence the entire data can be treated as a
“valid” test set for estimating heterogeneous treatment effect of Vioxx with the TC outcome.
Results from Table 5: In Table 5, we report the analogous results for cells C˜1, C˜2, and C˜3,
and their union ∪3j=1C˜j , first for the TC outcome, and then the GI outcome. For these cells,
the generalization to the holdout test set is weaker, with only C˜1 and C˜3 having test set CATE
values that remain substantially positive. Furthermore, the test set t-statistic values are smaller.
All these observations are unsurprising given the rarity of the TC outcome—in particular, only
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#evts/size CATE Est. τ̂C∩S (std) t-statistic TC∩S
Dataset S STRAIN STEST STRAIN STEST STRAIN STEST
†SVAL
Cell C
GI Event (GI-stratified split)
PPH=1 36/501 8/129 -0.057 (0.023) -0.055 (0.042) -1.89 -1.01 -0.99 (0.27)
PSTRDS=1,
HYPGRP=1
39/1008 6/238 -0.050 (0.012) -0.037 (0.021) -3.17 -1.06 -1.57 (0.22)
PSTRDS=1,
ELDERLY=1
46/894 9/227 -0.051 (0.015) -0.063 (0.026) -2.74 -2.00 -1.38 (0.17)
Union 79/1905 19/471 -0.038 (0.009) -0.047 (0.018) -3.15 -2.22 -1.59 (0.20)
All 142/6460 35/1616 -0.016 (0.004) -0.016 (0.007) - - -
TC Event (entire data)
PPH=1 2/630 -0.006 (0.004) -2.66
PSTRDS=1,
HYPGRP=1
11/1246 0.008 (0.005) 0.44
PSTRDS=1,
ELDERLY=1
16/1121 0.015 (0.007) 1.42
Union 21/2376 0.007 (0.004) 0.55
All 59/8076 0.006 (0.002) -
Table 4: Results for the final cells selected after StabilizedCellSearch for the GI event, namely
C1 = {PPH=1}, C2 = {PSTRDS=1,HYPGRP=1} and C3 = {PSTRDS=1,ELDERLY=1} from
Section 6.3. We also report the results for the other outcome, namely TC event, on the entire data
(all 8076 patients). In the column †SVAL, we report the mean t-statistics (and standard deviation in
parentheses) across the 12 different folds of the training data STRAIN obtained from the 3 random
CV splits {cv orig, cv 0, cv 1}.
12/1616 individuals in the test set STEST experienced an event. Nonetheless, the test set TC-
CATE estimates for C˜1 and C˜3 support the view that the treatment effect is stronger on these
subgroups, while the GI-CATE estimates do not suggest that these subgroups benefit especially
strongly from the treatment with Vioxx.
7 Discussion
In this work, we have made three major contributions: (I) We have re-analyzed a dataset from the
1999-2000 VIGOR study, a randomized clinical trial of 8076 patients, and found three clinically
relevant subgroups, together totalling 29.4% of the study size, for which the treatment drug Vioxx
provides significantly larger benefits than the ATE. (II) Our work is an illustration of how clinical
trial data can be analyzed to provide a basis for differential treatment decisions in subgroups in
order to optimize outcomes. We call this novel methodology StaDISC, and develop it by building on
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#evts/size CATE Est. τ̂C∩S (std) t-statistic TC∩S
Dataset S STRAIN STEST STRAIN STEST STRAIN STEST
†SVAL
Cell C
TC Event (TC-stratifed split)
ASPFDA=1 13/263 5/58 0.062 (0.025) 0.103 (0.074) 2.28 1.38 1.09 (0.20)
MALE=1,
ELDERLY=1
12/383 0/111 0.040 (0.017) 0 (0) 2.09 -1.16 0.85 (0.24)
ASCGRP=1 15/376 6/78 0.044 (0.020) 0.047 (0.060) 2.05 0.74 1.04 (0.23)
Union 24/716 6/175 0.042 (0.013) 0.024 (0.028) 3.09 0.77 1.55 (0.13)
All 47/6460 12/1616 0.006 (0.002) 0.005 (0.004) - - -
GI Event (entire data)
ASPFDA=1 6/321 -0.027 (0.016) -0.71
MALE=1,
ELDERLY=1
17/494 -0.045 (0.016) -1.85
ASCGRP=1 8/454 -0.028 (0.013) -0.96
Union 25/891 -0.040 (0.011) -2.27
All 177/8076 -0.016 (0.003) -
Table 5: Results for the final cells selected after StabilizedCellSearch for the TC event, namely
C˜1 = {ASPFDA=1}, C˜2 = {MALE=1,ELDERLY=1} and C˜3 = {ASCGRP=1} from Section 6.3.
We also report the results for the other outcome, namely GI event, on the entire data (all 8076
patients). In the column †SVAL, we report the mean t-statistics (and standard deviation in paren-
theses) across the 12 different folds of the training data STRAIN obtained 4 each from the 3 random
CV splits {cv orig, cv 0, cv 1}.
the PCS framework [66], the calibration literature, and recent developments in CATE estimation.
(III) Our work introduces the PCS framework to the causal inference community, and provides a
template for a more informative understanding of heterogeneous treatment effects.
An important point to note is that the notions of estimated treatment effects ATE, CATE and
subgroup CATE (defined in equation (1)) used in this work and more broadly in CATE estimation,
measure the difference in the adverse event risk in the treatment group to that in the control group.
However, when investigating the efficacy of medical interventions, medical professionals are often
more interested in relative risk, which measures the ratio of the two risks. This alternate conception
of treatment effect in terms of relative risk changes the meaning of heterogeneity. For instance, the
subgroup C1 {PPH=1} has a relative risk of 0.43 with respect to GI events, which is barely any
different than the population relative risk of 0.46. On the other hand, because the baseline risk of
individuals in this subgroup is far higher than the rest of the population, the subgroup CATE is
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Estimator M A1,2 A2,3 A3,4 A4,5 A1,min
t logistic 1.00 0.67 0.83 0.25 1.00
causal forest 2 1.00 0.50 0.83 0.17 1.00
x lasso 1.00 0.50 0.58 0.67 1.00
x rf 1.00 0.42 0.42 0.67 1.00
t lasso 1.00 0.42 0.50 0.58 0.92
x logistic 1.00 0.33 0.50 0.75 0.92
s xgb 1.00 0.67 0.58 0.58 0.92
r lassolasso 0.92 0.42 0.42 0.92 0.92
r rfrf 0.92 0.50 0.42 0.50 0.92
r lassorf 0.92 0.42 0.42 0.42 0.92
causal forest 1 0.92 0.67 0.75 0.50 0.83
x xgb 0.92 0.33 0.50 0.83 0.83
t xgb 0.92 0.42 0.67 0.17 0.83
t rf 0.92 0.75 0.50 0.33 0.83
causal tree 2 0.92 0.75 0.25 0.42 0.75
s rf 0.83 0.58 0.67 0.42 0.75
causal tree 1 0.83 0.58 0.17 0.67 0.67
Estimator M A1,2 A2,3 A3,4 A4,5 A5,max
t lasso 0.33 0.42 0.42 1.00 1.00
x xgb 0.33 0.50 0.58 0.92 0.92
x logistic 0.50 0.50 0.42 0.92 0.92
r rfrf 0.25 0.42 0.50 0.92 0.83
s rf 0.42 0.42 0.42 0.92 0.83
x lasso 0.50 0.33 0.50 0.83 0.75
t rf 0.33 0.25 0.67 0.83 0.75
x rf 0.50 0.33 0.58 0.83 0.75
t logistic 0.33 0.25 0.58 0.83 0.75
r lassorf 0.17 0.42 0.42 0.92 0.75
causal forest 1 0.67 0.33 0.67 0.92 0.75
causal forest 2 0.50 0.08 0.33 0.92 0.75
r lassolasso 0.17 0.75 0.50 0.75 0.67
causal tree 2 0.25 0.08 0.33 0.83 0.25
t xgb 0.08 0.08 0.25 0.75 0.08
(a) GI Event (b) TC Event
Table 6: Estimator-wise values of the mean scoresAj,j+1 (8a) for j = 1, 2, 3, 4 for both GI and TC
events, A1,min (8b) for the GI event, and A5,max (8c) for the TC event, where the mean was taken
over the 12 validation folds, 4 each from the 3 random CV splits {cv orig,cv 0,cv 1}. In each
column the maximum score is highlighted in bold. The estimators are listed in the order sorted by
the value in last column. Recall that each column was plotted earlier as a boxplot in Fig. 4(a).
similarly inflated.
We do not attempt to debate which notion of heterogeneity is better since it is context-
dependent. Nevertheless, given the popularity of relative risk in the medical literature, in our
future work we plan to develop a formal framework for subgroup discovery with respect to relative
risk by adapting generic CATE estimation methods, and consequently extend StaDISC for relative
risk estimation.
There are several other extensions of StaDISC that remain interesting future directions. First,
StaDISC is currently motivated and defined for randomized experiments. We intend to formulate
a statistical framework that would also make it applicable to observational studies. Second, the
cell search step of StaDISC only works with binary features. One can either propose to incorporate
continuous features through either careful binary encoding using quantile-thresholding, or through
amending the cell search procedure. Third, we have thus far applied StaDISC to the GI and TC
outcomes in the VIGOR study one at a time and a joint investigation with multiple outcomes, even
more generally, is an interesting future direction.
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Stab(C)-score in %
with Gtop = G˜q
Cell C for GI event q = 0.2 q = 0.3 Mean
{PPH=1} 92 92 92
{PSTRDS=1, HYPGRP=1} 36 54 45
{PSTRDS=1, ELDERLY=1} 37 48 42
{PNAPRXN=0, PSTRDS=1, ELDERLY=1} 23 18 21
{PNAPRXN=0, HYPGRP=1, PSTRDS=1} 25 8 17
{PSTRDS=1, PNSAIDS=0} 8 23 15
{WHITE=0, PSTRDS=1, ELDERLY=1} 18 3 11
{CHLGRP=1, HYPGRP=1} 17 2 10
{OBESE=1, WHITE=0, PSTRDS=1} 10 8 9
{PNAPRXN=0, ELDERLY=1} 0 18 9
{OBESE=1, WHITE=0} 0 17 8
{HYPGRP=1, PNSAIDS=0} 16 0 8
{WHITE=0, PNSAIDS=0} 14 0 7
{OBESE=1, WHITE=0, PNAPRXN=0} 3 10 7
{OBESE=1, PSTRDS=1, HYPGRP=1} 5 8 7
{PSTRDS=1, HYPGRP=1, ELDERLY=1} 12 0 6
{WHITE=0, PSTRDS=1, PNSAIDS=0} 10 2 6
{CHLGRP=1} 0 11 6
{PNAPRXN=0, HYPGRP=1} 0 10 5
{OBESE=1, PNSAIDS=0} 4 6 5
Stab(C)-score in %
with Gtop = G˜
c
q
Cell C for TC event q = 0.9 q = 0.8 Mean
{ASPFDA=1} 82 50 66
{MALE=1, ELDERLY=1} 70 57 64
{ASCGRP=1} 32 54 43
{MALE=1} 0 62 31
{ELDERLY=1, SMOKE=1} 22 27 25
{MALE=1, ELDERLY=1, US=1} 30 0 15
{MALE=1, US=1} 0 26 13
{OBESE=1, ELDERLY=1} 0 21 10
{MALE=1, WHITE=1, ELDERLY=1} 20 0 10
{MALE=1, ASCGRP=1} 18 0 9
{WHITE=1, OBESE=1, ELDERLY=1} 0 15 8
{MALE=1, PPH=0, ELDERLY=1} 13 0 7
{MALE=1, WHITE=1} 0 12 6
{PPH=0, US=1, ASCGRP=1} 2 8 5
{WHITE=1, ELDERLY=1, SMOKE=1} 7 3 5
{ELDERLY=1, US=1, SMOKE=1} 7 3 5
{MALE=1, PPH=0} 0 9 4
{ELDERLY=1, US=1, CHLGRP=1} 0 8 4
{CHLGRP=1, ASCGRP=1} 8 0 4
{MALE=1, ELDERLY=1, SMOKE=1} 7 0 3
(a) GI Event (b) TC Event
Table 7: Stab(C)-scores (in % rounded to nearest integer) for the top 20 cells C found by
CellSearch-methodology for quantile-based top subgroups Gtop of the ensemble CATE estima-
tor. The cells are sorted by the “Mean” column of Stab(C)-scores, which in turn denote the
average of the the scores in second and third columns. For each score column, cells corresponding
to top-3 scores are displayed in bold. The choices q = 0.2, 0.3 for the GI event in panel (a), and
q = 0.8, 0.9 for the TC event in panel (b) were made based on the results reported in Table 3 and
the discussion around it.
A Derivation of variance formula in t-statistic
In this section, we derive the formula for the variance of τ̂G−τ̂ATE, thereby justifying the formula for
the plug-in estimator used in the definition of the t-statistic, which we repeat here for convenience.
TG :=
τ̂G − τ̂ATE√
V̂ar(τ̂G − τ̂ATE)
, (16)
We first group terms to get
τ̂G − τ̂ATE =
(
1
|G ∩T|
∑
i∈G∩T
Yi(1)− 1|G ∩C|
∑
i∈G∩C
Yi(0)
)
−
(
1
|T|
∑
i∈T
Yi(1)− 1|C|
∑
i∈C
Yi(0)
)
= α1
∑
i∈G∩T
Yi(1) + α0
∑
i∈G∩C
Yi(0) + β1
∑
i∈Gc∩T
Yi(1) + β0
∑
i∈Gc∩C
Yi(0)
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where
α1 =
(
1
|G ∩T| −
1
|T|
)
, α0 = −
(
1
|G ∩C| −
1
|C|
)
, β1 = − 1|T| , and β0 =
1
|C| .
Next, observe that because we have assumed i.i.d. sampling from an infinite distribution, each sum
is fully independent of the other sums. Applying the linearity of variance thus gives us
Var(τ̂G − τ̂ATE) = α21 |G ∩T| ·Var
[
Y (1)
∣∣ G]+ α20 |G ∩C| ·Var [Y (0) ∣∣ G]
+ β21 |Gc ∩T| ·Var
[
Y (1)
∣∣ G]+ β20 |Gc ∩C| ·Var [Y (0) ∣∣ G]
Simplifying this formula leads to
Var(τ̂G − τ̂ATE) =
(
1− |G ∩C||C|
)2
· Var
[
Y (0)
∣∣ G ∩C]
|G ∩C| +
(
1− |G ∩T||T|
)2
· Var
[
Y (1)
∣∣ G ∩T]
|G ∩T|
+
( |Gc ∩C|
|C|
)2
· Var
[
Y (0)
∣∣ Gc ∩C]
|Gc ∩C| +
( |Gc ∩T|
|T|
)2
· Var
[
Y (1)
∣∣ Gc ∩T]
|Gc ∩T| .
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